Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 18 years of age~* ≥ 6th grade English literacy~* agree to use personal or study-provided smartphone/applications~* agree to complete phone-based or in-person surveys throughout 26 week study~* expired CO \> 6 ppm at baseline visit (suggesting current smoker)~* currently smoke ≥ 5 cigarettes per day~* willing to make quit attempt 7 days after baseline visit~Exclusion Criteria:~* \< 18 years of age~* history of seizures or allergic reaction to varenicline~* report current suicidality~* taking anti-depressants or anti-psychotic medications~* pregnant or planning to become pregnant~* currently breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Varenicline/Counseling + Med Reminders (VAR+REM) (Type: EXPERIMENTAL): Participants will receive behavioral tobacco cessation counseling, a 13-week course of varenicline, and automated medication reminders via their smartphones.
- Varenicline/Counseling (VAR+NREM) (Type: EXPERIMENTAL): Participants will receive behavioral tobacco cessation counseling, a 13-week course of varenicline, and no automated medication reminders.
- Varenicline/Counseling + Oral NRT (VAR+NRT+NREM) (Type: EXPERIMENTAL): Participants will receive behavioral tobacco cessation counseling, a 13-week course of varenicline, 12 weeks of oral nicotine replacement therapy (NRT; gum or lozenge), and no automated medication reminders.
- Varenicline/Counseling + Oral NRT + Med Reminders (VAR+NRT+REM) (Type: EXPERIMENTAL): Participants will receive behavioral tobacco cessation counseling, a 13-week course of varenicline, 12 weeks of oral nicotine replacement therapy (NRT; gum or lozenge), and automated medication reminders via their smartphones.

Based on this trial design, predict the completion outcome and termination type (if applicable).